The worse outcome in patients with high ATF4 expression was consistent with our mouse tumor data, demonstrating that wild‐type tumors had stronger tumorigenicity and metastatic capability than their ATF4 knockout counterparts. This evidence concerns the gene ATF4 and neoplasm.